ARGX - Total Utang marang Modal argenx BVBA

Logo perusahaan publik argenx SE (ARGX)

The debt-to-equity ratio for argenx SE (ARGX) provided by the GURU.Markets platform shows a value of 0.01. This trend is supported by sales of the blockbuster Vyvgart and the expansion of its applications. The business relies on an innovative immunological cluster and a protected antibody portfolio. The company's rapid growth is driving the active recruitment of leading scientists, while employee turnover remains minimal.

ARGX: Total Utang marang Modal argenx 04.07.2022 - 30.10.2026

Rincian analitis perusahaan argenx SE

- rega lan prakiraan konsensus rega:
Bagan rega argenx|ARGX - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar argenx|ARGX - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham argenx|ARGX - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku argenx.com|ARGX - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas argenx SE|ARGX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal argenx SE|ARGX - Gunggung utang perusahaan|Utang marang nilai buku argenx|ARGX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan argenx|Likuiditas cepet argenx.com
- informasi bathi lan kelipatan valuasi:
ARGX - Penghasilan resik
Analisis dhasar perusahaan:argenx
Barang utama argenx BVBA

Investors assess an asset's financial stability through the balance of debt and equity. This metric is calculated as the ratio of total liabilities to equity, measuring the business's degree of reliance on external financing. For argenx SE (ARGX), low leverage is critically important given the high dependence on the commercial success of Vyvgart. Conservative leverage reduces bankruptcy risk in the face of intensifying competition. The current total debt-to-equity ratio confirms the company's margin of safety.

Analisis pesaing argenx SE

Utang marang Ekuitas BioNTech|Abivax - Utang Agregat marang Ekuitas|Total Utang marang Modal ADMA|PTGX (Protagonist Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal IMVT (Immunovant, Inc.)|Total Utang marang Modal kiniksa.com KNSA|GRFS - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ADPT (Adaptive Biotech)|Celldex (CLDX) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Aurinia Corp|BCRX (BioCryst) - Total Utang marang Modal|Total Utang marang Modal veratx.com|Rasio Total Utang marang Ekuitas DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ABCL (abcellera.com)|Koefisien Total Utang marang Modal Tourmaline (TRML)|PGEN - Utang marang Ekuitas|pharming.com (PHAR) - Rasio Total Utang marang Ekuitas|Nektar Therapeutics Inc. (NKTR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Upstream Bio, Inc.|Rasio Total Utang marang Ekuitas ZBIO|Total Utang marang Modal Immunome Bio|Utang marang Ekuitas Gossamer Bio, Inc. (GOSS)|kalvista.com - Rasio Utang marang Ekuitas|Total Utang marang Modal SEPN (Septerna)|Pieris Pharma (PVLA) - Utang marang Modal|Savara Corp - Total Utang marang Modal|RIGL - Total Utang marang Modal|AnaptysBio, Inc. (ANAB) - Utang marang Ekuitas|astriatx.com - Rasio Kabeh Utang marang Dana Pribadi|ENGN (enGene) - Total Utang marang Modal|RAPT - Rasio Utang marang Modal|Total Utang marang Modal JBIO|ACRS - Utang marang Modal|Utang marang Ekuitas Kyverna Therapeutics KYTX|TLSA: Rasio Utang marang Ekuitas|CABA: Rasio Total Utang marang Ekuitas|VTYX (Ventyx Biosciences Inc.) - Rasio Utang marang Ekuitas|THTX (Theratechnologies Inc) - Rasio Total Utang marang Ekuitas|Avalo Therapeutics Inc - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Eledon Pharmaceuticals|agenusbio.com (AGEN) - Koefisien Total Utang marang Modal|Total Utang marang Modal CLYM|ZURA - Utang marang Modal|Total Utang marang Modal ATYR (aTyr)|Total Utang marang Modal Adagene Inc ADAG|IMA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi STTK (Shattuck Labs, Inc.)|EQ: Total Utang marang Modal|Rasio Utang marang Modal Connect Biopharma Holdings Limited CNTB|Rasio Total Utang marang Ekuitas IMUX|Rasio Utang marang Ekuitas ATRA (Atara Biotherapeutics Inc)|Utang marang Ekuitas InflaRx N.V. (IFRX)|XFOR: Utang Agregat marang Ekuitas|Total Utang marang Modal ACET (Adicet Bio, Inc.)|Rasio Kabeh Utang marang Dana Pribadi CELU|INmune Bio Corp - Total Utang marang Modal|BRNS - Total Utang marang Modal|Kezar Life Sciences (KZR) - Utang marang Ekuitas|sabbiotherapeutics.com - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Akari Therapeutics Plc|Rasio Total Utang marang Ekuitas Enlivex Therapeutics, Ltd. (ENLV)|Total Utang marang Modal QTTB|Total Utang marang Modal GeoVax Corp (GOVX)|Edesa Biotech, Inc. - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi IBIO|Carisma Tx - Total Utang marang Modal|Koefisien Total Utang marang Modal XTL Biopharmaceuticals Ltd XTLB|boltbio.com (BOLT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas HCW Biologics|Utang marang Ekuitas Aptevo Therapeutics, Inc.|Rasio Total Utang marang Ekuitas AIM ImmunoTech, Inc. (AIM)|Rasio Total Utang marang Ekuitas ADTX (Aditxt)|Total Utang marang Modal GRI Bio Inc (GRI)|Utang marang Ekuitas XORTX XRTX|HIND: Rasio Utang marang Ekuitas|Revelation Biosciences - Total Utang marang Modal|Utang marang Modal indaptusrx.com|SCNI: Total Utang marang Modal|CalciMedica (CALI) - Total Utang marang Modal|Utang marang Ekuitas Affimed NV|ALLK: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal HOOK|igmbio.com (IGMS) - Rasio Utang marang Modal|Total Utang marang Modal ITOS (iTeos Therapeutics, Inc.)|Ocean Biomedical Inc (OCEA) - Utang marang Modal|TCBP - Utang marang Ekuitas|THRD (Third Harmonic Bio Inc) - Rasio Utang marang Ekuitas